Page last updated: 2024-09-03
mosapride and uracil
mosapride has been researched along with uracil in 1 studies
Compound Research Comparison
| Studies (mosapride) | Trials (mosapride) | Recent Studies (post-2010) (mosapride) | Studies (uracil) | Trials (uracil) | Recent Studies (post-2010) (uracil) |
|---|---|---|---|---|---|
| 286 | 90 | 142 | 11,300 | 715 | 2,532 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Kaji, T; Nonogaki, K | 1 |
Other Studies
1 other study(ies) available for mosapride and uracil
| Article | Year |
|---|---|
Mosapride, a selective serotonin 5-HT4 receptor agonist, and alogliptin, a selective dipeptidyl peptidase-4 inhibitor, exert synergic effects on plasma active GLP-1 levels and glucose tolerance in mice.
Topics: Animals; Benzamides; Blood Glucose; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Glucagon-Like Peptide 1; Glucose Tolerance Test; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Morpholines; Piperidines; Serotonin 5-HT4 Receptor Agonists; Uracil | 2015 |